{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:56:23Z","timestamp":1781340983754,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03201-3","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:33:27Z","timestamp":1762619607000},"page":"917-927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Xuebijing combined with levosimendan on immune function and coagulation function in sepsis patients with myocardial injury"],"prefix":"10.1007","volume":"59","author":[{"given":"Wenbo","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"key":"3201_CR1","doi-asserted-by":"crossref","unstructured":"Mirijello A, Tosoni A (2020) and G. On behalf of the internal medicine sepsis Study, New strategies for treatment of sepsis. Med (Kaunas) 56(10):527","DOI":"10.3390\/medicina56100527"},{"issue":"2","key":"3201_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ccc.2021.11.013","volume":"38","author":"JA Kellum","year":"2022","unstructured":"Kellum JA, Formeck CL, Kernan KF, Gomez H, Carcillo JA (2022) Subtypes and mimics of sepsis. Crit Care Clin 38(2):195\u2013211","journal-title":"Crit Care Clin"},{"issue":"2","key":"3201_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.7861\/clinmedicine.18-2-146","volume":"18","author":"T Evans","year":"2018","unstructured":"Evans T (2018) Diagnosis and management of sepsis. Clin Med (Lond) 18(2):146\u2013149","journal-title":"Clin Med (Lond)"},{"issue":"5","key":"3201_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7748\/en.2019.e1926","volume":"27","author":"A Hunt","year":"2019","unstructured":"Hunt A (2019) Sepsis: an overview of the signs, symptoms, diagnosis, treatment and pathophysiology. Emerg Nurse 27(5):32\u201341","journal-title":"Emerg Nurse"},{"key":"3201_CR5","doi-asserted-by":"crossref","unstructured":"Xie Y, Zhang J, Jin W, Tian R, Wang R (2021) Role of Thrombospondin\u20131 in sepsis\u2013induced myocardial injury. Mol Med Rep 27(6):113","DOI":"10.3892\/mmr.2023.13000"},{"issue":"1","key":"3201_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/iep.12459","volume":"104","author":"N Zeng","year":"2023","unstructured":"Zeng N, Jian Z, Zhu W, Xu J, Fan Y, Xiao F (2023) KLF13 overexpression protects sepsis-induced myocardial injury and LPS-induced inflammation and apoptosis. Int J Exp Pathol 104(1):23\u201332","journal-title":"Int J Exp Pathol"},{"issue":"8","key":"3201_CR7","volume":"10","author":"L Gao","year":"2025","unstructured":"Gao L, Shi Q, Sun B, Zhang X, Zheng P, Zhou L et al (2025) C-FLIP protects cardiac microcirculation in Sepsis-induced myocardial dysfunction via FUNDC1-mediated regulation of mitochondrial autophagy. JACC: Basic to Translational Science 10(8):101257","journal-title":"JACC: Basic to Translational Science"},{"issue":"8","key":"3201_CR8","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.7150\/ijbs.111288","volume":"21","author":"W Yang","year":"2025","unstructured":"Yang W, Cao Y, Li J, Zhang X, Liu X, Tian Y et al (2025) Pathogenesis and treatment strategies of sepsis-induced myocardial injury: modern and traditional medical perspectives. Int J Biol Sci 21(8):3478\u20133504","journal-title":"Int J Biol Sci"},{"key":"3201_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153543","volume":"85","author":"W Zhou","year":"2021","unstructured":"Zhou W, Lai X, Wang X, Yao X, Wang W, Li S (2021) Network pharmacology to explore the anti-inflammatory mechanism of Xuebijing in the treatment of sepsis. Phytomedicine 85:153543","journal-title":"Phytomedicine"},{"issue":"10","key":"3201_CR10","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.18632\/aging.204740","volume":"15","author":"CF Bi","year":"2023","unstructured":"Bi CF, Liu J, Hao SW, Xu ZX, Ma X, Kang XF et al (2023) Xuebijing injection protects against sepsis-induced myocardial injury by regulating apoptosis and autophagy via mediation of PI3K\/AKT\/mTOR signaling pathway in rats. Aging 15(10):4374\u20134390","journal-title":"Aging"},{"issue":"17","key":"3201_CR11","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S et al (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375(17):1638\u20131648","journal-title":"N Engl J Med"},{"issue":"4","key":"3201_CR12","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-483","volume":"10","author":"J Shi","year":"2022","unstructured":"Shi J, Chen Y, Zhi H, An H, Hu Z (2022) Levosimendan protects from sepsis-inducing cardiac dysfunction by suppressing inflammation, oxidative stress and regulating cardiac mitophagy via the PINK-1-Parkin pathway in mice. Ann Transl Med 10(4):212","journal-title":"Ann Transl Med"},{"issue":"1","key":"3201_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.22551\/2023.38.1001.10236","volume":"10","author":"F Mangini","year":"2023","unstructured":"Mangini F, Bruno E, Caramia R, Flora R, Muscogiuri E, Medico A et al (2023) Effectiveness of Levosimendan and role of cardiac magnetic resonance in cardiogenic shock due to COVID-19 related lymphocytic myocarditis in the course of viral sepsis. Arch Clin Cases 10(1):32\u201338","journal-title":"Arch Clin Cases"},{"issue":"1","key":"3201_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-022-01663-z","volume":"22","author":"ZS Li","year":"2022","unstructured":"Li ZS, Wang K, Pan T, Sun YH, Liu C, Cheng YQ et al (2022) The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis. BMC Anesthesiol 22(1):135","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"3201_CR15","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jcrc.2015.05.017","volume":"30","author":"A Zangrillo","year":"2015","unstructured":"Zangrillo A, Putzu A, Monaco F, Oriani A, Frau G, De Luca M et al (2015) Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials. J Crit Care 30(5):908\u2013913","journal-title":"J Crit Care"},{"issue":"17","key":"3201_CR16","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.08.58","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Chen K (2016) Vasoactive agents for the treatment of sepsis. Ann Transl Med 4(17):333","journal-title":"Ann Transl Med"},{"issue":"5","key":"3201_CR17","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1177\/0300060519837103","volume":"47","author":"F Yang","year":"2019","unstructured":"Yang F, Zhao LN, Sun Y, Chen Z (2019) Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. J Int Med Res 47(5):1817\u20131828","journal-title":"J Int Med Res"},{"issue":"1","key":"3201_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2483986","volume":"47","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhang G, Mao W, Sun S, Tao S, Gao Y et al (2025) Xuebijing injection alleviates septic acute kidney injury by modulating inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress. Ren Fail 47(1):2483986","journal-title":"Ren Fail"},{"key":"3201_CR19","doi-asserted-by":"crossref","unstructured":"Lv J, Guo X, Zhao H, Zhou G, An Y (2022) Xuebijing Administration Alleviates Pulmonary Endothelial Inflammation and Coagulation Dysregulation in the Early Phase of Sepsis in Rats. J Clin Med, 11(22)","DOI":"10.3390\/jcm11226696"},{"issue":"7","key":"3201_CR20","first-page":"1414","volume":"104","author":"F Bosa Ojeda","year":"2024","unstructured":"Bosa Ojeda F, Mendez Vargas C, Lacalzada Almeida J, Izquierdo Gomez MM, Jimenez Sosa A, Rodriguez Jimenez C et al (2024) Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the LEVOCEST trial. Catheter Cardiovasc Interv 104(7):1414\u20131422","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"3201_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"key":"3201_CR22","unstructured":"Zhang J, Liu XL, Sun XF, Zhang J (2025) Observation on the Efficacy of Xuebijing Injection Combined with Levosimendan in the Treatment of Acute Myocardial Infarction Complicated with Heart Failure [J]. Cardio - cerebrovasc Dis Prev Treat, 25(05): pp. 31\u201334\u2009+\u200957"},{"issue":"1","key":"3201_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SHK.0000000000002372","volume":"62","author":"JQ Wu","year":"2024","unstructured":"Wu JQ, Wang YX, Su D, Shao TH, Ding XX, Sun T et al (2024) Effects of levosimendan on diaphragmatic dysfunction in patients with sepsis. Shock 62(1):63\u201368","journal-title":"Shock"},{"issue":"6","key":"3201_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0254-6272(17)30003-1","volume":"36","author":"H Zhang","year":"2016","unstructured":"Zhang H, Wei L, Zhao G, Liu S, Zhang Z, Zhang J et al (2016) Protective effect of Xuebijing injection on myocardial injury in patients with sepsis: a randomized clinical trial. J Tradit Chin Med 36(6):706\u2013710","journal-title":"J Tradit Chin Med"},{"issue":"Suppl 1","key":"3201_CR25","first-page":"67","volume":"61","author":"I Srzic","year":"2022","unstructured":"Srzic I, Adam VN, Tunjic Pejak D (2022) Sepsis definition: what\u2019s new in the treatment guidelines. Acta Clin Croat 61(Suppl 1):67\u201372","journal-title":"Acta Clin Croat"},{"issue":"1","key":"3201_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/10408363.2013.764490","volume":"50","author":"JD Faix","year":"2013","unstructured":"Faix JD (2013) Biomarkers of sepsis. Crit Rev Clin Lab Sci 50(1):23\u201336","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"3201_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03469-6","volume":"20","author":"F Guo","year":"2022","unstructured":"Guo F, Zhu X, Wu Z, Zhu L, Wu J, Zhang F (2022) Clinical applications of machine learning in the survival prediction and classification of sepsis: coagulation and heparin usage matter. J Transl Med 20(1):265","journal-title":"J Transl Med"},{"issue":"2","key":"3201_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.15537\/smj.2015.2.9895","volume":"36","author":"SY Hou","year":"2015","unstructured":"Hou SY, Feng XH, Lin CL, Tan YF (2015) Efficacy of xuebijing for coagulopathy in patients with sepsis. Saudi Med J 36(2):164\u2013169","journal-title":"Saudi Med J"},{"issue":"7","key":"3201_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jcma.2016.12.008","volume":"80","author":"HC Huang","year":"2017","unstructured":"Huang HC, Tsai HJ, Wang CC, Tsao CM, Ka SM, Liaw WJ et al (2017) Levosimendan mitigates coagulopathy and organ dysfunction in rats with endotoxemia. J Chin Med Assoc 80(7):432\u2013441","journal-title":"J Chin Med Assoc"},{"issue":"4","key":"3201_CR30","first-page":"399","volume":"33","author":"L Chen","year":"2021","unstructured":"Chen L, Zhang A, Li Q, Cui Y, Yuan G (2021) Evaluation of clinical value of Xuebijing combined with human Immunoglobulin in severe and critically ill patients with coronavirus disease 2019]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 33(4):399\u2013404","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"16","key":"3201_CR31","doi-asserted-by":"publisher","first-page":"8501","DOI":"10.18632\/aging.204990","volume":"15","author":"XF Kang","year":"2023","unstructured":"Kang XF, Lu XL, Bi CF, Hu XD, Li Y, Li JK et al (2023) Xuebijing injection protects sepsis induced myocardial injury by mediating TLR4\/NF-kappaB\/IKKalpha and JAK2\/STAT3 signaling pathways. Aging 15(16):8501\u20138517","journal-title":"Aging"},{"issue":"11","key":"3201_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s12519-023-00717-7","volume":"19","author":"WY Zhang","year":"2023","unstructured":"Zhang WY, Chen ZH, An XX, Li H, Zhang HL, Wu SJ et al (2023) Analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in pediatric sepsis by integrating bioinformatics and machine learning. World J Pediatr 19(11):1094\u20131103","journal-title":"World J Pediatr"},{"key":"3201_CR33","doi-asserted-by":"publisher","first-page":"1124334","DOI":"10.3389\/fendo.2023.1124334","volume":"14","author":"S Shao","year":"2023","unstructured":"Shao S, Zhou D, Feng J, Liu Y, Baturuhu H, Yin et al (2023) Regulation of inflammation and immunity in sepsis by E3 ligases. Front Endocrinol (Lausanne) 14:1124334","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3201_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156629","volume":"140","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zheng R, Jiang H, Zhang X, Peng M, Jiang T et al (2025) Therapeutic efficacy of Xuebijing injection in treating severe acute pancreatitis and its mechanisms of action: a comprehensive survey. Phytomedicine 140:156629","journal-title":"Phytomedicine"},{"issue":"8","key":"3201_CR35","first-page":"658","volume":"36","author":"RQ Yao","year":"2020","unstructured":"Yao RQ, Ren C, Wang LX, Dong N, Wu Y, Yao YM (2020) Influence of Xuebijing injection and its component paeoniflorin on immune function and survival rate of septic rats. Zhonghua Shao Shang Za Zhi 36(8):658\u2013664","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"3201_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.899753","volume":"9","author":"Y Su","year":"2022","unstructured":"Su Y, Zhang Y, Yuan H, Shen C (2022) Efficacy of Xuebijing combined with Ulinastatin in the treatment of traumatic sepsis and effects on inflammatory factors and immune function in patients. Front Surg 9:899753","journal-title":"Front Surg"},{"issue":"17","key":"3201_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm8965","volume":"8","author":"K Yang","year":"2022","unstructured":"Yang K, Fan M, Wang X, Xu J, Wang Y, Gill PS et al (2022) Lactate induces vascular permeability via disruption of VE-cadherin in endothelial cells during sepsis. Sci Adv 8(17):eabm8965","journal-title":"Sci Adv"},{"key":"3201_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep09704","volume":"5","author":"M Adam","year":"2015","unstructured":"Adam M, Meyer S, Knors H, Klinke A, Radunski UK, Rudolph TK et al (2015) Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure. Sci Rep 5:9704","journal-title":"Sci Rep"},{"issue":"2","key":"3201_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118057","volume":"10","author":"Q Xu","year":"2015","unstructured":"Xu Q, Liu J, Wang Z, Guo X, Zhou G, Liu Y et al (2015) Heat stress-induced disruption of endothelial barrier function is via PAR1 signaling and suppressed by Xuebijing injection. PLoS ONE 10(2):e0118057","journal-title":"PLoS ONE"},{"issue":"1","key":"3201_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bj.2021.10.004","volume":"45","author":"EP Lee","year":"2022","unstructured":"Lee EP, Wu HP, Chan OW, Lin JJ, Hsia SH (2022) Hemodynamic monitoring and management of pediatric septic shock. Biomed J 45(1):63\u201373","journal-title":"Biomed J"},{"issue":"9","key":"3201_CR41","first-page":"5624","volume":"15","author":"X Sun","year":"2023","unstructured":"Sun X, Wei C, Li L, Qu C (2023) Levosimendan improves cardiac function, hemodynamics, and body inflammation in patients with acute myocardial infarction and heart failure. Am J Transl Res 15(9):5624\u20135632","journal-title":"Am J Transl Res"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03201-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:32:43Z","timestamp":1781339563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03201-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3201"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03201-3","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}